Tatiana Foltánová, Ján Lietava
Insufficient effectiveness or therapy failure requires the modification of the therapy. The aim of the study was to define the relationship between modification of the therapy (adding, removing or switching the drug) and cardiovascular morbidity and total mortality in the group of 849 high cardiovascular risk patients. Therapy interventions were very frequent. Adding the drug into the therapy was the most frequent therapy intervention. Switching was the most infrequent therapy intervention. The modification of the pharmacotherapy was asociated with higher probability of CV morbidity – CV hospitalisations, however it decreased the risk of total mortality. According to our results we suppose that dynamic modification of the therapy reflects the changes in clinical status of the patient – is beneficial for the patient.